In the United States, racial and ethnic minorities are more likely to die from colorectal cancer (CRC) than non-Hispanic whites (nHw). African-Americans (AA) and Hispanic Americans (HA) are the two largest minority populations in the United States. Despite increased efforts to increase CRC screening, AA and certain segments of the HA population continue to experience increased incidence and mortality when compared to nHw. Even with the implementation of the Patient Protection and Affordable Care Act (PPACA), disparities in CRC screening will continue to exist until specific interventions are implemented in the context of AA and HA, since both populations are not monolithic rather, heterogeneous in nature. The purpose of this review is to highlight the differences in incidence and mortality as well as the interventions that have been performed to close the incidence and mortality gap between AA and HA when compared to nHw.
Christian S Jackson and Kenneth J Vega